Tauroursoursodeoxycholic acid, brand name tudcabil    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎1

97. 潰瘍性大腸炎 [臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04114292
(ClinicalTrials.gov)
January 17, 201925/9/2019TUDCA as a Therapy for Ulcerative Colitis (UC)A Phase I Open Label Study of the Efficacy and Safety of Tudca in Ulcerative ColitisUlcerative ColitisDrug: Tauroursoursodeoxycholic acid, brand name TudcabilWashington University School of MedicineCrohn's and Colitis FoundationRecruiting18 Years65 YearsAll13Phase 1United States